MEDPACE HOLDINGS INC (1MEDP.MI) Stock Price & Overview
BIT:1MEDP • US58506Q1094
Current stock price
The current stock price of 1MEDP.MI is 380.6 EUR. Today 1MEDP.MI is down by -27.34%.
1MEDP.MI Key Statistics
- Market Cap
- 10.801B
- P/E
- 30.74
- Fwd P/E
- 26.28
- EPS (TTM)
- 12.38
- Dividend Yield
- N/A
1MEDP.MI Stock Performance
1MEDP.MI Stock Chart
1MEDP.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1MEDP.MI.
1MEDP.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 1MEDP.MI. Both the health and profitability get an excellent rating, making 1MEDP.MI a very profitable company, without any liquidiy or solvency issues.
1MEDP.MI Earnings
On February 9, 2026 1MEDP.MI reported an EPS of 4.67 and a revenue of 708.45M. The company beat EPS expectations (9.56% surprise) and beat revenue expectations (0.75% surprise).
1MEDP.MI Forecast & Estimates
19 analysts have analysed 1MEDP.MI and the average price target is 426.96 EUR. This implies a price increase of 12.18% is expected in the next year compared to the current price of 380.6.
For the next year, analysts expect an EPS growth of 19.47% and a revenue growth 19.22% for 1MEDP.MI
1MEDP.MI Groups
Sector & Classification
1MEDP.MI Financial Highlights
Over the last trailing twelve months 1MEDP.MI reported a non-GAAP Earnings per Share(EPS) of 12.38. The EPS increased by 25.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.36% | ||
| ROA | 24.7% | ||
| ROE | 147.46% | ||
| Debt/Equity | 0 |
1MEDP.MI Ownership
1MEDP.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| DIM | SARTORIUS STEDIM BIOTECH | 31.35 | 16.259B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 31.54 | 16.157B | ||
| SRT3 | SARTORIUS AG-VORZUG | 35.51 | 16.137B | ||
| SRT | SARTORIUS AG | 28.5 | 12.655B | ||
| QIA | QIAGEN N.V. | 15.06 | 7.226B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 12.38 | 2.033B | ||
| EVT | EVOTEC SE | N/A | 1.555B | ||
| 1EVT | EVOTEC SE | N/A | 1.501B | ||
| GXI | GERRESHEIMER AG | 7.86 | 716.36M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 11.85 | 180.892M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1MEDP.MI
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Company Info
IPO: 2016-08-11
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO US
Employees: 5900
Phone: 13026587581
MEDPACE HOLDINGS INC / 1MEDP.MI FAQ
Can you describe the business of MEDPACE HOLDINGS INC?
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Can you provide the latest stock price for MEDPACE HOLDINGS INC?
The current stock price of 1MEDP.MI is 380.6 EUR. The price decreased by -27.34% in the last trading session.
Does MEDPACE HOLDINGS INC pay dividends?
1MEDP.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1MEDP stock?
1MEDP.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the GICS sector and industry of 1MEDP stock?
MEDPACE HOLDINGS INC (1MEDP.MI) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the number of employees for MEDPACE HOLDINGS INC?
MEDPACE HOLDINGS INC (1MEDP.MI) currently has 5900 employees.